SEC Form 4/A · accession 0001192482-18-000195
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Winston J Churchill
Director
Period of report
May 4, 2018
Accepted (ET)
May 10, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $11.32 | May 4, 2018 | A | 8,965 | A | — | May 4, 2028 | Common Stock | 8,965 | 8,965 | D |
Explanation of responses
- F1This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018.
- F2The stock option will vest on May 4, 2019.